REQUEST A DEMO
Total
USD $0.00
Search more companies

Ipolypharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Ipolypharma Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Ipolypharma Bt. is a company based in Hungary, with its head office in Dregelypalank. The company operates in the Pharmacies and Drug Stores industry. It was established on March 20, 1998. Ipolypharma Bt. currently employs 6 (2024) people. From the latest financial highlights, Ipolypharma Bt. reported a net sales revenue increase of 7.55% in 2023. During that time, Ipolypharma Bt.’s total assets grew by 12.86%. In 2023, Ipolypharma Bt.’s net profit margin decreased by 0.51%.

Headquarters
Honti ut 28.
Dregelypalank; Nograd; Postal Code: 2646

Contact Details: Purchase the Ipolypharma Bt. report to view the information.

Website: http://www.ipolypharma.t-online.hu

Basic Information
Total Employees:
Purchase the Ipolypharma Bt. report to view the information.
Outstanding Shares:
Purchase the Ipolypharma Bt. report to view the information.
Registered Capital:
Purchase the Ipolypharma Bt. report to view the information.
Financial Auditors:
Purchase the Ipolypharma Bt. report to view the information.
Incorporation Date:
March 20, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ipolypharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.55%
Total operating revenue
7%
Operating profit (EBIT)
-3.85%
EBITDA
-5.96%
Net Profit (Loss) for the Period
0.51%
Total assets
12.86%
Total equity
-10.6%
Operating Profit Margin (ROS)
-0.87%
Net Profit Margin
-0.51%
Return on Equity (ROE)
3.75%
Quick Ratio
-0.16%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?